PROVIDER PROFILE · NPI 1750597654

Heidi KozicMD

Micrographic Dermatologic SurgeryPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,440

Unique beneficiaries

—

Total services

1,769

Distinct HCPCS

Medicare payment

$611K

Peer benchmark

Total Medicare services vs. 23 Micrographic Dermatologic Surgery providers in PA — above median (cohort median 1,967).

PRESCRIBING · PART D · 2024

Total Rx claims

977

Beneficiaries

—

Total drug cost

$8K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Mupirocin866 claims

Gentamicin Sulfate111 claims

QUALITY · MIPS · 2024

Final MIPS score

82.7

Quality

70.4

Cost

79.5

Improvement activities

40.0

Promoting interop.

91.0

Payment adjustment

0.32%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$38

Payment records

By payment type

Food and Beverage$38

REFERRAL NETWORK

Where Heidi Kozic's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Edward Chan Dermatology · Media, PA	122	223
Center For Dermatopathology, P.C. Clinical Laboratory · Media, PA	73	89
John Laskas Dermatology · Media, PA	38	57
Kelly Burkert Dermatology · Media, PA	25	32
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	22	29
CROZER-CHESTER MEDICAL CENTER	20	22
Karen Riggs Dermatology · Media, PA	12	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history